Thomas Holst‐Hansen
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 10%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 8
-
- Pharmacology and Obesity Treatment 6
- Co-authors
- Peter Nørkjær Laursen (2 shared papers)Filip K. Knop (2 shared papers)W. Timothy Garvey (1 shared paper)Julio Rosenstock (1 shared paper)Domenica Rubino (1 shared paper)Vanita R. Aroda (1 shared paper)Michael Junkin (1 shared paper)Savaş Tay (1 shared paper)
- Journals
- Diabetes Obesity and Metabolism (3 papers)Canadian Journal of Cardiology (1 paper)Diabetes (1 paper)The Lancet (1 paper)Science Advances (1 paper)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Thomas Holst‐Hansen
11 papers receiving 282 citations
Thomas Holst‐Hansen's Hit Papers
Peers
Comparison fields: 5 of 50
- Endocrinology, Diabetes and Metabolism 206
- Pharmacology 156
- Physiology 82
- Pharmacy 10
- Molecular Biology 85
Countries citing papers authored by Thomas Holst‐Hansen
This map shows the geographic impact of Thomas Holst‐Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Holst‐Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Holst‐Hansen more than expected).
Fields of papers citing papers by Thomas Holst‐Hansen
This network shows the impact of papers produced by Thomas Holst‐Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Holst‐Hansen. The network helps show where Thomas Holst‐Hansen may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Holst‐Hansen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2023 | 231 |
| 2 | 2022 | 24 | |
| 3 | 2023 | 10 | |
| 4 | 2024 | 6 | |
| 5 | 2022 | 5 | |
| 6 | 2023 | 4 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2025 | 1 | |
| 10 | 2022 | 1 | |
| 11 | 2023 | 1 |
About Thomas Holst‐Hansen
Thomas Holst‐Hansen is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology, Molecular Biology, Surgery and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 286 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (8 papers), Pharmacology and Obesity Treatment (6 papers), Metabolism, Diabetes, and Cancer (5 papers), Obesity and Health Practices (2 papers), Bariatric Surgery and Outcomes (2 papers), Gastric Cancer Management and Outcomes (2 papers), NF-κB Signaling Pathways (1 paper) and Obesity, Physical Activity, Diet (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (206 citations), Pharmacology (156 citations), Physiology (82 citations), Pharmacy (10 citations) and Molecular Biology (85 citations). Thomas Holst‐Hansen has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Peter Nørkjær Laursen, Filip K. Knop, W. Timothy Garvey, Julio Rosenstock, Domenica Rubino, Vanita R. Aroda, Michael Junkin, Savaş Tay, Ala Trusina and Sara Saheb Kashaf. Their work appears in journals such as Diabetes Obesity and Metabolism, Canadian Journal of Cardiology, Diabetes, The Lancet and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.